SIRT1 and breast cancer: In summary, this study suggests that the herbal recipe SLC has the potential to act as an agent for inhibiting OXPHOS through the PDK1/PDHA1 and SIRT1/PGC-1α/NRF1/TFAM signaling axis to treat HER2-positive breast cancer.